A prognosis and impact factor analysis of DC-CIK cell therapy for patients with hepatocellular carcinoma undergoing postoperative TACE

Zhang, J; Li, HZ; Gao, DZ; Zhang, BF; Zheng, MJ; Lun, MY; Wei, MX; Duan, R; Guo, MM; Hua, JJ; Liu, Q; Bai, J; Liu, H; Zheng, JN; Yao, H

Zheng, JN; Yao, H (reprint author), Xuzhou Med Univ, 84 West Huaihai Rd, Xuzhou 221002, Jiangsu, Peoples R China.

CANCER BIOLOGY & THERAPY, 2018; 19 (6): 475

Abstract

Dendritic cell-cytokine-induced killer (DC-CIK) cell therapy has been experimentally implemented for enhancing anti-tumoral immunity in patients with ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索